Levoleucovorin
Levoleucovorin is the enantiomerically active form of Folinic acid.
A study from authors at Georgetown University have shown that there is no safety or efficacy benefit to levoleucovorin.[1]
References
- ↑ Kovoor, P. A.; Karim, S. M.; Marshall, J. L. (2009). "Is levoleucovorin an alternative to racemic leucovorin? A literature review". Clinical Colorectal Cancer. 8 (4): 200–6. doi:10.3816/CCC.2009.n.034. PMID 19822510.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.